Key result
Low-dose prostacyclin preserves post-CABG renal function with ~35 mL/min higher 24-hour creatinine clearance.
Why the study?
Renal failure after coronary bypass surgery remains a significant problem prolonging hospital care and reducing survival, especially in patients with poor cardiac function.
Does perioperative low-dose prostacyclin preserve renal function in patients with ejection fraction <40% undergoing primary coronary bypass surgery?
RCT (n=34)
randomized
No
Does perioperative low-dose prostacyclin preserve renal function in patients with ejection fraction <40% undergoing primary coronary bypass surgery?
Perioperative low-dose prostacyclin infusion preserves renal function in high-risk patients with reduced ejection fraction undergoing coronary bypass surgery.
Answers are grounded in this paper and cite their sources.
Supports perioperative prostacyclin for renal preservation in low-EF CABG; extends evidence for targeted renoprotection in high-risk cardiac surgery.
Objective Renal failure after bypass is still a threatening problem prolonging hospital care and reducing overall survival. The following pilot study was aimed to analyze whether perioperative low-dose prostacyclin infusion is able to preserve renal function in a selected group of patients who according to a poor cardiac function were stratified as high risk for the development of renal failure after bypass. Design Prospective randomized study. Setting Tertiary care university medical center. Patients Thirty-four patients scheduled for primary cardiac bypass surgery were included in the study (prostacyclin n = 17, control n = 17). Inclusion criteria were normal renal function before surgery and a cardiac ejection fraction <40%. Interventions Low-dose prostacyclin (2 ng/kg/min) was added to the standard anesthetic protocol. Infusion was started immediately before surgery and was continued for a maximum of 48 Measurements and main results Significant differences in the endogenous creatinine clearance were found between the prostacyclin and the control group. Whereas there was a significant drop in the creatinine clearance at 6 hrs after surgery in the control group with a prolonged recovery period, values in the prostacyclin group remained stable. Creatinine clearance before intervention was 100 +/- 22 mL/min in the control group and 91 +/- 22 mL/min in the prostacyclin group, values at 24 hr were 68 +/- 34 mL/min vs. 103 +/- 37 mL/min, respectively (p < .01). Significant findings in favor for the prostacyclin group were also found for urine output and the fractional excretion rate of sodium. Conclusion This first pilot study indicates that low-dose prostacyclin may be of substantial value for preserving renal function in high-risk patients after coronary bypass surgery.
No takes yet. Share an insight, caveat, or question.
Morgera et al. (2002) conducted an RCT in Primary cardiac bypass surgery (n=34). Low-dose prostacyclin vs. Standard anesthetic protocol (control) was evaluated on Creatinine clearance at 24 hours (p=< .01). Perioperative low-dose prostacyclin preserved creatinine clearance at 24 hours compared to control in high-risk patients undergoing coronary bypass surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: